KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.311 $0.311 Friday, 27th Jan 2023 TYME stock ended at $0.311. During the day the stock fluctuated 0% from a day low at $0.311 to a day high of $0.311.
90 days $0.311 $0.311
52 weeks $0.219 $0.405

Historical Tyme Technologies Inc prices

Date Open High Low Close Volume
Apr 11, 2022 $0.309 $0.319 $0.301 $0.303 490 610
Apr 08, 2022 $0.340 $0.340 $0.313 $0.313 408 344
Apr 07, 2022 $0.330 $0.345 $0.324 $0.330 229 700
Apr 06, 2022 $0.330 $0.355 $0.300 $0.345 910 900
Apr 05, 2022 $0.344 $0.356 $0.322 $0.324 664 300
Apr 04, 2022 $0.360 $0.362 $0.350 $0.352 244 100
Apr 01, 2022 $0.340 $0.356 $0.340 $0.350 356 745
Mar 31, 2022 $0.354 $0.360 $0.342 $0.353 297 002
Mar 30, 2022 $0.342 $0.360 $0.338 $0.350 245 472
Mar 29, 2022 $0.339 $0.364 $0.339 $0.360 897 597
Mar 28, 2022 $0.370 $0.370 $0.330 $0.343 551 000
Mar 25, 2022 $0.359 $0.369 $0.344 $0.363 589 100
Mar 24, 2022 $0.360 $0.362 $0.342 $0.343 379 100
Mar 23, 2022 $0.360 $0.362 $0.343 $0.349 487 600
Mar 22, 2022 $0.338 $0.370 $0.330 $0.354 684 810
Mar 21, 2022 $0.335 $0.340 $0.325 $0.330 252 617
Mar 18, 2022 $0.324 $0.340 $0.320 $0.332 429 785
Mar 17, 2022 $0.299 $0.326 $0.298 $0.326 639 000
Mar 16, 2022 $0.286 $0.298 $0.286 $0.295 308 600
Mar 15, 2022 $0.288 $0.290 $0.282 $0.285 361 800
Mar 14, 2022 $0.296 $0.300 $0.287 $0.288 559 400
Mar 11, 2022 $0.310 $0.320 $0.291 $0.295 733 800
Mar 10, 2022 $0.312 $0.328 $0.300 $0.319 788 700
Mar 09, 2022 $0.300 $0.315 $0.300 $0.312 584 200
Mar 08, 2022 $0.300 $0.300 $0.280 $0.295 662 000
Click to get the best stock tips daily for free!

About Tyme Technologies Inc

Tyme Technologies Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the ... TYME Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT